EP2504466A1 - Controlled electrochemical activation of carbon-based electrodes - Google Patents

Controlled electrochemical activation of carbon-based electrodes

Info

Publication number
EP2504466A1
EP2504466A1 EP10831966A EP10831966A EP2504466A1 EP 2504466 A1 EP2504466 A1 EP 2504466A1 EP 10831966 A EP10831966 A EP 10831966A EP 10831966 A EP10831966 A EP 10831966A EP 2504466 A1 EP2504466 A1 EP 2504466A1
Authority
EP
European Patent Office
Prior art keywords
sensor
electrode
sensor electrode
electric potential
activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP10831966A
Other languages
German (de)
French (fr)
Other versions
EP2504466A4 (en
EP2504466B1 (en
Inventor
Mikhail Briman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proxim Diagnostics Corp
Original Assignee
Briman Mikhail
PROXIM DIAGNOSTICS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Briman Mikhail, PROXIM DIAGNOSTICS filed Critical Briman Mikhail
Publication of EP2504466A1 publication Critical patent/EP2504466A1/en
Publication of EP2504466A4 publication Critical patent/EP2504466A4/en
Application granted granted Critical
Publication of EP2504466B1 publication Critical patent/EP2504466B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
    • G01N27/3276—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction being a hybridisation with immobilised receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/38—Cleaning of electrodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements

Definitions

  • the present invention relates generally to an apparatus and process to perform activation of electrodes in a controlled manner.
  • activation of an electrode refers to a process that improves the electrochemical properties of a given electrode. For example, activation could affect the rate of electrochemical reaction.
  • a possible method for such activation on carbon-based electrodes is an electrochemical one, where the process involves placing an electrode in a liquid medium at a selected potential as compared to the reference electrode. It has been reported that such a procedure both cleans the electrode surface and for various carbon-based materials introduces functional groups that may include carboxyl or quinone through faradic type reaction; those reactions that involve electron transfer from electrolyte to electrode.
  • activation Reported electrochemical activation procedures involve glassy carbon electrodes, pyrolytic carbon films, and screen-printed electrodes.
  • the prior art describes the electrochemical activation (hereafter "activation") process as applying a certain fixed potential to the working electrode for a fixed amount of time.
  • the present invention describes a process and apparatus by which electrochemical activation is combined with some other measurement technique that can assess the degree of activation.
  • a process may employ measurement of electrochemical capacitance, because this value may increase as more electrochemically active surface groups are introduced during a given activation process.
  • the activation process may be allowed to continue until a target degree of activation is met, which may be some predefined electrode capacitance value.
  • novel electrode apparatuses may be employed to perform the aforementioned processes.
  • Certain embodiments of the present invention may provide an advantage over alternate methods with respect to improved reproducibility of electrodes. For example, where the capacitance of an electrode depends both on electrochemically available area of an electrode and the number of surface functional groups, electrodes with narrower distribution of their given capacitances may translate to better reproducibility for other electrochemical reactions, compared with another group of electrodes where their capacitance values form a much broader distribution.
  • an electrode may be a carbon-based electrode, while in other embodiments of the present invention an electrode may comprising a different conductive materials (e.g., gold, platinum, palladium, etc.).
  • FIGS. 1A-1 E are schematic representations of an electrode apparatus and device fabrication process according to certain embodiments of the present invention.
  • FIG. 2 is a graph of sensor potential as a function of time during activation process according to certain embodiments of the present invention.
  • FIG. 3 is a graph of capacitance of all 8 pads of an experimental embodiment as a function of activation cycle according to certain embodiments of the present invention (note: the activation process started on the 7th measurement);
  • FIGS. 4A and 4B are graphs showing the normalized capacitance for pads before and after activation according to certain embodiments of the present invention.
  • FIG. 5 is a graph showing the response of the differently activated 8-plex devices to HRP according to certain embodiments of the present invention.
  • FIGS. 6A and 6B are graphs showing sample real-time activation data (Controlled activation (FIG. 6A) versus Fixed number of cycles (FIG. 6B)) according to certain embodiments of the present invention
  • FIG. 7 is a graph showing the response of 8-plex device to different concentrations of HRP (log-log scale) according to certain embodiments of the present invention (note: the ratio of the response to 0.01 ng/ml to 0 ng/ml is approximately ten); and
  • FIG. 8 is a table showing a performance comparison between controlled and fixed number of cycles activation protocols.
  • An electrode apparatus comprised an 8 pad electrode screen-printed sensor ("8-plex device"). This device was employed to demonstrate activation processes according to certain embodiments of the present invention.
  • the 8-plex device may be fabricated by first screen-printing silver ink contact traces 1 10 on a plastic flexible substrate.
  • silver / silver chloride (Ag/AgCI) inks may then be screen-printed to form a reference electrode 120.
  • carbon inks e.g., proprietary inks
  • 8 sensor pads working electrodes, sensor electrodes 130.
  • an insulation layer 140 may then be screen- printed, for example, to have only sensing pads and reference electrodes be exposed to liquid.
  • a plastic top part 150 with 8 openings may then be glued on top of the plastic to form 8 isolated wells for liquid application.
  • Electrode apparatuses e.g., 8-plex devices as described above, according to certain embodiments of the present invention may be connected to an electronic measuring setup that allows setting the user-defined voltage V (V) on the reference electrode and measuring individual pad currents I (A).
  • controlled activation may be represented by the following procedure.
  • a sensor may be exposed to an aqueous solution. Any number of aqueous solutions may be used, including but not limited to phosphate buffered saline (PBS) pH 7.2 and phosphate-citrate buffer pH 5.0, without departing from the scope of the present invention.
  • PBS phosphate buffered saline
  • phosphate-citrate buffer pH 5.0 phosphate-citrate buffer pH 5.0
  • a small sine wave may be superimposed around V CO ntroi for a time that would be necessary enough to measure the capacitance (T meaS ure)-
  • both sensor potential V(t) and current l(t) may be recorded, and at the end of each cycle the last sine wave may be analyzed and its amplitude l amp i, offset l 0 f S t, and phase shift ( ⁇ ) between voltage and current may be calculated.
  • the capacitance may then be estimated by the following equation:
  • V amp i is the amplitude of the applied potential wave
  • f is the frequency
  • the activation cycle may be ended when the capacitance becomes greater or equal to some predefined target value Cfi na i.
  • real-time controlled activation data with Cf in ai set to 600 nF e.g., pads would target this value as their final capacitance
  • a key merit of such embodiments is that the pads do not reach the target capacitance value at the same time, emphasizing the possible importance of activation process control for each individual pad.
  • the capacitance of 8-plex device was measured at different voltages before and after activation process for certain embodiments of the present invention. The data was then normalized to the average capacitance of all 8 pads.
  • a controlled activation procedure according to certain embodiments of the present invention may be employed to improve the precision of a given immunological electrochemical biosensor that has carbon-based electrodes.
  • the sample embodiment below describes a HRP (horseradish peroxidase) enzyme sensor that served as a model system.
  • Immunological sensors were constructed by first exposing each pad of an 8-plex device to 100 ⁇ _ of PBS buffer containing anti-HRP antibodies. Next, some devices were controlled activated to 1000 nF per pad, others to 400 nF per pad, while the rest were not activated (the "as is" capacitance was approximately 1 15 nF per pad). The activation to higher than 1000 nF capacitance values appeared to be unreasonable since it could lead to pad degradation and undesirable higher response to zero control. After that, all devices were left at room temperature for 2 hours to allow antibody adsorption to the pad surface. Finally, all devices were washed and blocked for 1 hour at room temperature with a protein-based blocking buffer to prevent non-specific background.
  • device responses indicate that in certain embodiments of the present invention, controlled activation to 1000 nF may provide the best sensitivity (higher slope) while keeping background signal almost as low as in the case of non-activated device.
  • C fin ai was set to 1000 nF.
  • immunological sensors were constructed by first exposing each pad of 8-plex device to 100 ⁇ _ of PBS buffer containing anti-HRP antibodies and then some of 8-plex devices went through a controlled activation procedure for each pad with Cfinai set to 1000 nF. Other 8-plex devices were activated for the fixed number of cycles without individual pad control to reach average 8-plex pad capacitance 1000 nF. Devices were left at room temperature for 2 hours to allow antibody adsorption to the pad surface. After that, devices were washed and blocked for 1 hour at room temperature with a protein-based blocking buffer to prevent nonspecific background. In both controlled and fixed number of cycles activation protocols, a dose response after incubation with HRP for 60 minutes were very similar with a typical data shown in FIG. 8.
  • response data of an 8-plex device according to certain sample embodiments of the present invention to different concentrations of HRP indicated that a ratio of the response to 0.01 ng/ml to 0 ng/ml is approximately ten.
  • embodiments of the present invention for electrochemical sensors with carbon- based electrodes may include, but are not limited to, the following routine.
  • a set of screen-printed carbon-based electrodes is placed in the controlled environment chamber (for example 37 C, 50% relative humidity) with each sensor connected to an electronic setup capable of performing controlled activation procedure described above.
  • a solution containing the bio- functionalization reagents for example antibodies in PBS buffer is introduced on top of the sensors and controlled activation procedure is carried out for each sensor.
  • the quality control is performed at the same time: If a sensor fails to reach predefined Cfinal value within certain range of activation cycles, then this sensor is considered as failed and will not be used for the next steps.
  • the sensors that pass the QC step will go through the next manufacturing steps that can include but not limited to non-specific binding blocking, placing of dried reporter antibodies next to sensor area, integration of the electrodes with plastic sample delivery cartridges, and packaging integrated cartridges for the long-term storage.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Electrochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Certain embodiments of the present application describe a process to perform activation of carbon based electrodes in a controlled manner, where the degree of activation is monitored and calculated simultaneously with the ongoing activation process. Such an approach is intended to improve the reproducibility of electrodes that may include, but are not limited to, the following parameters: electrochemical capacitance, electrochemical transfer coefficient, ampehometric response to enzymatic reactions.

Description

CONTROLLED ELECTROCHEMICAL ACTIVATION OF CARBON-BASED ELECTRODES
FIELD OF THE INVENTION
[0001 ] This application claims priority to U.S. Provisional Application No. 61/263,774, filed November 23, 2009 and entitled "CONTROLLED ELECTROCHEMICAL ACTIVATION OF CARBON-BASED ELECTRODES," which is hereby incorporated herein by reference.
FIELD OF THE INVENTION
[0002] The present invention relates generally to an apparatus and process to perform activation of electrodes in a controlled manner.
BACKGROUND OF THE INVENTION
[0003] In electrochemistry, activation of an electrode refers to a process that improves the electrochemical properties of a given electrode. For example, activation could affect the rate of electrochemical reaction. A possible method for such activation on carbon-based electrodes is an electrochemical one, where the process involves placing an electrode in a liquid medium at a selected potential as compared to the reference electrode. It has been reported that such a procedure both cleans the electrode surface and for various carbon-based materials introduces functional groups that may include carboxyl or quinone through faradic type reaction; those reactions that involve electron transfer from electrolyte to electrode.
[0004] Reported electrochemical activation procedures involve glassy carbon electrodes, pyrolytic carbon films, and screen-printed electrodes. The prior art describes the electrochemical activation (hereafter "activation") process as applying a certain fixed potential to the working electrode for a fixed amount of time.
SUMMARY OF THE INVENTION
[0005] The present invention describes a process and apparatus by which electrochemical activation is combined with some other measurement technique that can assess the degree of activation.
[0006] In certain embodiments of the present invention, a process may employ measurement of electrochemical capacitance, because this value may increase as more electrochemically active surface groups are introduced during a given activation process. The activation process may be allowed to continue until a target degree of activation is met, which may be some predefined electrode capacitance value.
[0007] In certain embodiments of the present invention, novel electrode apparatuses may be employed to perform the aforementioned processes.
[0008] Certain embodiments of the present invention may provide an advantage over alternate methods with respect to improved reproducibility of electrodes. For example, where the capacitance of an electrode depends both on electrochemically available area of an electrode and the number of surface functional groups, electrodes with narrower distribution of their given capacitances may translate to better reproducibility for other electrochemical reactions, compared with another group of electrodes where their capacitance values form a much broader distribution.
[0009] In certain embodiments of the present invention an electrode may be a carbon-based electrode, while in other embodiments of the present invention an electrode may comprising a different conductive materials (e.g., gold, platinum, palladium, etc.).
[0010] Other features and advantages of the invention will be apparent from the accompanying drawings and from the detailed description. One or more of the above-disclosed embodiments, in addition to certain alternatives, are provided in further detail below with reference to the attached figures. The invention is not limited to any particular embodiment disclosed; the present invention may be employed in not only sensor applications, but in other applications as well. As used herein, "substantially" shall mean that at least 40% of components are of a given type.
BRIEF DESCRIPTION OF THE DRAWINGS
[001 1 ] The invention is better understood from reading the following detailed description of the preferred embodiments, with reference to the accompanying figures in which:
[0012] FIGS. 1A-1 E are schematic representations of an electrode apparatus and device fabrication process according to certain embodiments of the present invention;
[0013] FIG. 2 is a graph of sensor potential as a function of time during activation process according to certain embodiments of the present invention;
[0014] FIG. 3 is a graph of capacitance of all 8 pads of an experimental embodiment as a function of activation cycle according to certain embodiments of the present invention (note: the activation process started on the 7th measurement);
[0015] FIGS. 4A and 4B are graphs showing the normalized capacitance for pads before and after activation according to certain embodiments of the present invention;
[0016] FIG. 5 is a graph showing the response of the differently activated 8-plex devices to HRP according to certain embodiments of the present invention;
[0017] FIGS. 6A and 6B are graphs showing sample real-time activation data (Controlled activation (FIG. 6A) versus Fixed number of cycles (FIG. 6B)) according to certain embodiments of the present invention; [0018] FIG. 7 is a graph showing the response of 8-plex device to different concentrations of HRP (log-log scale) according to certain embodiments of the present invention (note: the ratio of the response to 0.01 ng/ml to 0 ng/ml is approximately ten); and
[0019] FIG. 8 is a table showing a performance comparison between controlled and fixed number of cycles activation protocols.
[0020] Features, elements, and aspects of the invention that are referenced by the same numerals in different figures represent the same, equivalent, or similar features, elements, or aspects in accordance with one or more embodiments of the system. Those of ordinary skill in the art will appreciate that features, elements and aspects of the invention depicted in the figures in a similar or identical manner may be similar or identical, even if, for example, a plurality of such features, elements and aspects are not individually labeled.
DETAILED DESCRIPTION OF THE EMBODIMENTS
[0021 ] An electrode apparatus according to certain embodiments of the present invention comprised an 8 pad electrode screen-printed sensor ("8-plex device"). This device was employed to demonstrate activation processes according to certain embodiments of the present invention.
[0022] Referring to FIG. 1A, the 8-plex device may be fabricated by first screen-printing silver ink contact traces 1 10 on a plastic flexible substrate.
[0023] Referring to FIG. 1 B, silver / silver chloride (Ag/AgCI) inks may then be screen-printed to form a reference electrode 120.
[0024] Referring to FIG. 1 C, carbon inks (e.g., proprietary inks) may then be screen-printed to form 8 sensor pads (working electrodes, sensor electrodes) 130.
[0025] Referring to FIG. 1 D, an insulation layer 140 may then be screen- printed, for example, to have only sensing pads and reference electrodes be exposed to liquid.
[0026] Referring to FIG. 1 E, a plastic top part 150 with 8 openings may then be glued on top of the plastic to form 8 isolated wells for liquid application.
[0027] Electrode apparatuses, e.g., 8-plex devices as described above, according to certain embodiments of the present invention may be connected to an electronic measuring setup that allows setting the user-defined voltage V (V) on the reference electrode and measuring individual pad currents I (A).
[0028] Referring to FIG. 2, in certain embodiments of the present invention controlled activation may be represented by the following procedure. First, a sensor may be exposed to an aqueous solution. Any number of aqueous solutions may be used, including but not limited to phosphate buffered saline (PBS) pH 7.2 and phosphate-citrate buffer pH 5.0, without departing from the scope of the present invention. Next, the potential on the sensor may be applied in the cyclic manner as shown in FIG. 2.
[0029] After application of activation potential (Vact) versus the potential of the reference electrode for a certain period (Tact), the potential may be brought back down to the value (VCOntroi) where the sensor does not normally participate in faradic reactions with electrolyte, and the controlling capacitance measurement is performed. Finally, after staying there for a predefined amount of time (Twait) at the controlled potential, a small sine wave may be superimposed around VCOntroi for a time that would be necessary enough to measure the capacitance (TmeaSure)- For a given measurement, both sensor potential V(t) and current l(t) may be recorded, and at the end of each cycle the last sine wave may be analyzed and its amplitude lampi, offset l0fSt, and phase shift (φ) between voltage and current may be calculated. The capacitance may then be estimated by the following equation:
[0030] EQ. 1 : C = ^
Vampr 2 - 7i - f - sm(^)
[0031 ] where Vampi is the amplitude of the applied potential wave, and f is the frequency.
[0032] The activation cycle may be ended when the capacitance becomes greater or equal to some predefined target value Cfinai. [0033] In certain sample embodiments of the present invention, preferred values of the parameters mentioned above may be set but not limited to Vact =
1 .5 V, Tact = SeC, Vcontrol = 0.2 V, TWait =2 SeC, Tmeasure = 2 SeC, f = 10 Hz, Vampl =
0.015 V.
[0034] Referring to FIG. 3, real-time controlled activation data with Cfinai set to 600 nF (e.g., pads would target this value as their final capacitance) demonstrates functional aspects of certain embodiments of the present invention. Specifically, a key merit of such embodiments is that the pads do not reach the target capacitance value at the same time, emphasizing the possible importance of activation process control for each individual pad.
[0035] Referring to FIG. 4, in addition to the real-time data, the capacitance of 8-plex device was measured at different voltages before and after activation process for certain embodiments of the present invention. The data was then normalized to the average capacitance of all 8 pads.
[0036] Analysis of the experiment, corresponding to certain embodiments of the present invention, indicates that the data set of the minimal capacitances of 8 pads before activation process had coefficient of variation (CV%) approximately 3.1 %. After controlled activation procedure, CV% has been reduced to 0.4 % or roughly 8-fold improvement in the variability of their capacitance values. Further improvements in the algorithm of the controlled activation process described above may lead to even greater reductions of capacitance variability amongst, for example, large numbers of electrodes. [0037] A controlled activation procedure according to certain embodiments of the present invention, e.g., as described above, may be employed to improve the precision of a given immunological electrochemical biosensor that has carbon-based electrodes. The sample embodiment below describes a HRP (horseradish peroxidase) enzyme sensor that served as a model system.
[0038] Construction of the immunological sensor
[0039] Immunological sensors according to certain further embodiments of the present invention were constructed by first exposing each pad of an 8-plex device to 100 μΙ_ of PBS buffer containing anti-HRP antibodies. Next, some devices were controlled activated to 1000 nF per pad, others to 400 nF per pad, while the rest were not activated (the "as is" capacitance was approximately 1 15 nF per pad). The activation to higher than 1000 nF capacitance values appeared to be unreasonable since it could lead to pad degradation and undesirable higher response to zero control. After that, all devices were left at room temperature for 2 hours to allow antibody adsorption to the pad surface. Finally, all devices were washed and blocked for 1 hour at room temperature with a protein-based blocking buffer to prevent non-specific background.
[0040] To demonstrate the functionality of the aforementioned 8-plex device as an immunological sensor subsequent to activation, 8 pads of the 8-plex device were exposed to 10, 3.2, 1 , 0.32, 0.1 , 0.032, 0.010, 0 ng/mL HRP, such that the 8th pad served as a negative (zero) control. After 40 minute incubation with target (HRP) at room temperature, the 8-plex devices were washed and the fluid wells were filled with tetramethylbenzidine (TMB) based substrate that generates electrochemically active product in the presence of HRP.
[0041 ] Referring to FIG. 5, device responses indicate that in certain embodiments of the present invention, controlled activation to 1000 nF may provide the best sensitivity (higher slope) while keeping background signal almost as low as in the case of non-activated device. Based on this information, for the experiments described below, Cfinai was set to 1000 nF.
[0042] Referring to FIGS. 6A and 6B, to demonstrate precision improvement according to certain embodiments of the present invention, immunological sensors were constructed by first exposing each pad of 8-plex device to 100 μΙ_ of PBS buffer containing anti-HRP antibodies and then some of 8-plex devices went through a controlled activation procedure for each pad with Cfinai set to 1000 nF. Other 8-plex devices were activated for the fixed number of cycles without individual pad control to reach average 8-plex pad capacitance 1000 nF. Devices were left at room temperature for 2 hours to allow antibody adsorption to the pad surface. After that, devices were washed and blocked for 1 hour at room temperature with a protein-based blocking buffer to prevent nonspecific background. In both controlled and fixed number of cycles activation protocols, a dose response after incubation with HRP for 60 minutes were very similar with a typical data shown in FIG. 8.
[0043] Referring to FIG. 7, response data of an 8-plex device according to certain sample embodiments of the present invention to different concentrations of HRP (log-log scale) indicated that a ratio of the response to 0.01 ng/ml to 0 ng/ml is approximately ten.
[0044] In order to evaluate the precision improvement, the group of six 8- plex devices was exposed to 1 ng/ml HRP. Out of six sample devices, three went through controlled activation procedure, while the other three were activated for the fixed number of cycles. Results are summarized in FIG. 8, and indicate a coefficient of variation (CV%) for all pads for the group that went through controlled activation protocol was approximately two fold lower, 7.41 % as compared to 15.56%, or rather the precision was twice as tight compared with the uncontrolled group. Those of ordinary skill in the art will appreciate that with additional modification to the controlled activation method it may be possible to further improve the precision of the immunological sensor.
[0045] Larger scale embodiments of the controlled activation process described above are within the scope of the present invention. For example, embodiments of the present invention for electrochemical sensors with carbon- based electrodes may include, but are not limited to, the following routine. A set of screen-printed carbon-based electrodes is placed in the controlled environment chamber (for example 37 C, 50% relative humidity) with each sensor connected to an electronic setup capable of performing controlled activation procedure described above. Next, a solution containing the bio- functionalization reagents (for example antibodies in PBS buffer) is introduced on top of the sensors and controlled activation procedure is carried out for each sensor. The quality control (QC) is performed at the same time: If a sensor fails to reach predefined Cfinal value within certain range of activation cycles, then this sensor is considered as failed and will not be used for the next steps. The sensors that pass the QC step will go through the next manufacturing steps that can include but not limited to non-specific binding blocking, placing of dried reporter antibodies next to sensor area, integration of the electrodes with plastic sample delivery cartridges, and packaging integrated cartridges for the long-term storage.
[0046] The present invention has been described above with reference to preferred features and embodiments. Those skilled in the art will recognize, however, that changes and modifications may be made in these preferred embodiments without departing from the scope of the present invention. For example, those skilled in the art will recognize that although exemplary embodiments have been described above with respect to carbon-based electrodes, the present invention is also applicable to electrodes comprising other conductive materials (e.g., gold, platinum, palladium, etc.).

Claims

CLAIMS What is claimed is:
1 . A process for producing a sensor, comprising:
exposing a sensor electrode and a reference electrode to an aqueous solution;
applying an electric potential to the sensor electrode versus the reference electrode; and
measuring an electrochemical capacitance between the sensor electrode and the reference electrode.
2. The process of claim 1 , further comprising removing the electric potential once a predefined electrochemical capacitance value is reached.
3. The process of claim 2, wherein the electric potential is applied to the sensor electrode in a cyclic manner.
4. The process of claim 3, wherein the cyclic manner comprises:
setting the electric potential to a first potential level at which the sensor electrode substantially participates in faradic reactions with electrolytes in the aqueous solution; and setting the electric potential to a second potential level at which the sensor does not substantially participate in faradic reactions with electrolytes in the aqueous solution.
5. The process of claim 4, wherein the electrochemical capacitance is measured when the electric potential is at the second potential level.
6. The process of claim 5, wherein the sensor electrode is a carbon-based electrode.
7. The process of claim 6, wherein the process introduces functional groups to a surface of the sensor electrode through faradic type reactions.
8. The process of claim 7, wherein the process increases electrochemical property reproducibility of the surface of the sensor electrode compared to a process in which the electric potential is applied for a fixed number of cycles.
9. The process of claim 1 , wherein the process increases electrochemical property reproducibility of a surface of the sensor electrode compared to a process in which the electric potential is applied for a fixed number of cycles without regard to electrochemical capacitance.
10. The process of claim 1 , wherein the electric potential is applied to the sensor electrode in a cyclic manner.
1 1 . The sensor produced by the process of claim 1 .
12. The sensor of claim 1 1 , wherein the sensor electrode is a carbon-based electrode.
13. The sensor of claim 12, wherein functional groups are attached to a surface of the sensor electrode.
14. The sensor of claim 13, wherein the functional groups comprise at least one of carboxyl and quinone.
15. The sensor of claim 14, wherein the sensor is an immunological electrochemical biosensor.
16. A controlled-activation apparatus comprising:
a sensor electrode;
a reference electrode;
an aqueous solution in contact with and between the sensor electrode and the reference electrode; and a means for measuring electrochemical capacitance between the sensor electrode and the reference electrode.
17. The controlled-activation apparatus of claim 16, wherein the means for measuring electrochemical capacitance between the sensor electrode and the reference electrode comprises an electronic measuring setup that controls a voltage on the reference electrode and measures a current in the sensor electrode.
18. The controlled-activation apparatus of claim 17, wherein the sensor electrode is a carbon-based electrode.
19. The controlled-activation apparatus of claim 18, further comprising functional groups attached to a surface of the sensor electrode.
20. The controlled-activation apparatus of claim 19, wherein the sensor electrode comprises an immunological electrochemical biosensor.
EP10831966.6A 2009-11-23 2010-10-29 Controlled electrochemical activation of carbon-based electrodes Active EP2504466B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26377409P 2009-11-23 2009-11-23
PCT/US2010/054591 WO2011062738A1 (en) 2009-11-23 2010-10-29 Controlled electrochemical activation of carbon-based electrodes

Publications (3)

Publication Number Publication Date
EP2504466A1 true EP2504466A1 (en) 2012-10-03
EP2504466A4 EP2504466A4 (en) 2016-02-24
EP2504466B1 EP2504466B1 (en) 2019-11-20

Family

ID=44059919

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10831966.6A Active EP2504466B1 (en) 2009-11-23 2010-10-29 Controlled electrochemical activation of carbon-based electrodes

Country Status (4)

Country Link
US (2) US9000769B2 (en)
EP (1) EP2504466B1 (en)
JP (1) JP5792181B2 (en)
WO (1) WO2011062738A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2504466B1 (en) 2009-11-23 2019-11-20 Proxim Diagnostics Corporation Controlled electrochemical activation of carbon-based electrodes
WO2013015822A1 (en) 2011-07-25 2013-01-31 Mikhail Briman Cartridge for diagnostic testing
US9658190B2 (en) * 2014-12-18 2017-05-23 Genia Technologies, Inc. Printed electrode

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554064A (en) 1984-03-28 1985-11-19 Imasco-Cdc Research Foundation Dual working-electrode electrochemical detector for high performance liquid chromatography
EP0359831B2 (en) * 1988-03-31 2007-06-20 Matsushita Electric Industrial Co., Ltd. Biosensor and process for its production
US5096669A (en) 1988-09-15 1992-03-17 I-Stat Corporation Disposable sensing device for real time fluid analysis
DE3922873A1 (en) 1989-04-25 1990-10-31 Boehringer Mannheim Gmbh SPECIFIC ANTIBODIES AGAINST TROPONIN T, THEIR PRODUCTION AND USE IN A REAGENT FOR DETERMINING MUSCLE NECROSES
US5118403A (en) 1989-06-09 1992-06-02 The Research Foundation Of State Univ. Of N.Y. Glassy carbon linear array electrode
JP2652890B2 (en) * 1989-09-28 1997-09-10 株式会社テクノローグ How to measure hydrogen peroxide concentration
US5776563A (en) 1991-08-19 1998-07-07 Abaxis, Inc. Dried chemical compositions
US5413732A (en) 1991-08-19 1995-05-09 Abaxis, Inc. Reagent compositions for analytical testing
US5324400A (en) * 1992-12-04 1994-06-28 Hughes Aircraft Company Electrode preconditioning method for a plating bath monitoring process
AU689777B2 (en) 1993-05-17 1998-04-09 Fortron Bioscience, Inc. Assay for cardiac troponin I
US5399256A (en) * 1994-01-07 1995-03-21 Bioanalytical Systems, Inc. Electrochemical detector cell
JP3375000B2 (en) * 1994-01-24 2003-02-10 東陶機器株式会社 Inspection device for electrode for electrochemical measurement
US5697366A (en) 1995-01-27 1997-12-16 Optical Sensors Incorporated In situ calibration system for sensors located in a physiologic line
US6991907B1 (en) 1995-04-18 2006-01-31 Biosite, Inc. Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
US6627404B1 (en) 1995-04-18 2003-09-30 Biosite, Inc. Methods for improving the recovery of troponin I and T in membranes, filters and vessels
US5628890A (en) 1995-09-27 1997-05-13 Medisense, Inc. Electrochemical sensor
JPH09281067A (en) * 1996-04-17 1997-10-31 Daikin Ind Ltd Hydrogen peroxide electrode activity test method
DE69809391T2 (en) 1997-02-06 2003-07-10 Therasense, Inc. SMALL VOLUME SENSOR FOR IN-VITRO DETERMINATION
US5744096A (en) 1997-02-21 1998-04-28 Cholestech Corporation Automated immunoassay cassette
EP0983509B1 (en) 1997-05-14 2005-08-17 Biosite Diagnostics Inc. Rapid evaluation of the ratio of biological molecules
GB9709821D0 (en) 1997-05-15 1997-07-09 Clinical Diagnostic Chemicals Allergy assay
US6426230B1 (en) 1997-08-01 2002-07-30 Qualigen, Inc. Disposable diagnostic device and method
US6123820A (en) 1998-06-05 2000-09-26 Grupo Ch-Werfen, S.A. Sensor cartridges
US6281006B1 (en) 1998-08-24 2001-08-28 Therasense, Inc. Electrochemical affinity assay
JP4236746B2 (en) * 1998-12-03 2009-03-11 三桜工業株式会社 Method for inspecting oxidation degree of negative electrode material for battery
US6565738B1 (en) 1999-01-28 2003-05-20 Abbott Laboratories Diagnostic test for the measurement of analyte in abiological fluid
US6942771B1 (en) 1999-04-21 2005-09-13 Clinical Micro Sensors, Inc. Microfluidic systems in the electrochemical detection of target analytes
US6342347B1 (en) 1999-10-22 2002-01-29 Biosensor Systems Design., Inc. Electromagnetic sensor
US6923894B2 (en) 1999-11-11 2005-08-02 Apex Biotechnology Corporation Biosensor with multiple sampling ways
US6361958B1 (en) 1999-11-12 2002-03-26 Motorola, Inc. Biochannel assay for hybridization with biomaterial
US6875619B2 (en) 1999-11-12 2005-04-05 Motorola, Inc. Microfluidic devices comprising biochannels
US6750053B1 (en) 1999-11-15 2004-06-15 I-Stat Corporation Apparatus and method for assaying coagulation in fluid samples
US20030057108A1 (en) 1999-12-10 2003-03-27 Ramamurthi Sridharan Device and method for accelerated hydration of dry chemical sensors
US8329118B2 (en) 2004-09-02 2012-12-11 Honeywell International Inc. Method and apparatus for determining one or more operating parameters for a microfluidic circuit
US20020114739A1 (en) 2000-12-26 2002-08-22 Weigl Bernard H. Microfluidic cartridge with integrated electronics
US20050009101A1 (en) 2001-05-17 2005-01-13 Motorola, Inc. Microfluidic devices comprising biochannels
US6845327B2 (en) 2001-06-08 2005-01-18 Epocal Inc. Point-of-care in-vitro blood analysis system
US6824974B2 (en) * 2001-06-11 2004-11-30 Genorx, Inc. Electronic detection of biological molecules using thin layers
JP3869687B2 (en) * 2001-06-26 2007-01-17 独立行政法人科学技術振興機構 Microbial activity measuring apparatus and microbial activity measuring method
DE60233949D1 (en) 2001-08-20 2009-11-19 Biosite Inc DIAGNOSTIC MARKERS FOR STROKE AND HARNTRAUMA AND METHOD OF USE THEREOF
US8152991B2 (en) 2005-10-27 2012-04-10 Nanomix, Inc. Ammonia nanosensors, and environmental control system
US7419821B2 (en) 2002-03-05 2008-09-02 I-Stat Corporation Apparatus and methods for analyte measurement and immunoassay
US7238519B2 (en) 2002-06-07 2007-07-03 Cholestech Corporation Automated immunoassay cassette, apparatus and method
US7948041B2 (en) 2005-05-19 2011-05-24 Nanomix, Inc. Sensor having a thin-film inhibition layer
US7569393B2 (en) 2002-06-28 2009-08-04 International Technidyne Corporation Analytical test cartridge; and, methods
US20040018577A1 (en) 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
US8591817B1 (en) 2002-11-21 2013-11-26 Genefluidics, Inc. Elevated temperature assay system
US7842234B2 (en) 2002-12-02 2010-11-30 Epocal Inc. Diagnostic devices incorporating fluidics and methods of manufacture
CA2772050C (en) 2002-12-26 2016-09-06 Meso Scale Technologies, Llc. Assay cartridges and methods of using the same
US7419638B2 (en) 2003-01-14 2008-09-02 Micronics, Inc. Microfluidic devices for fluid manipulation and analysis
US9234867B2 (en) 2003-05-16 2016-01-12 Nanomix, Inc. Electrochemical nanosensors for biomolecule detection
US8425745B2 (en) 2006-10-06 2013-04-23 Nanomix, Inc. Electrochemical nanosensors for biomolecule detection
US7424318B2 (en) 2003-12-05 2008-09-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
CA2535833C (en) 2003-08-21 2013-11-26 Agamatrix, Inc. Method and apparatus for assay of electrochemical properties
US7682833B2 (en) 2003-09-10 2010-03-23 Abbott Point Of Care Inc. Immunoassay device with improved sample closure
US7723099B2 (en) 2003-09-10 2010-05-25 Abbott Point Of Care Inc. Immunoassay device with immuno-reference electrode
US20050118061A1 (en) 2003-11-28 2005-06-02 Sysmex Corporation Analyzer, assay cartridge and analyzing method
US7476360B2 (en) 2003-12-09 2009-01-13 Genefluidics, Inc. Cartridge for use with electrochemical sensor
US7776583B2 (en) 2004-06-03 2010-08-17 Meso Scale Technologies, Llc Methods and apparatuses for conducting assays
GB0414548D0 (en) * 2004-06-29 2004-08-04 Oxford Biosensors Ltd Electrode preconditioning
US7704730B2 (en) 2004-10-14 2010-04-27 Meso Scale Technologies, Llc Multiplexed assay methods
WO2006052891A1 (en) 2004-11-09 2006-05-18 The Regents Of The University Of California Analyte identification using electronic devices
GB2420180A (en) 2004-11-11 2006-05-17 Sensor Tech Ltd Method of electrochemical analysis of an analyte
US20060205061A1 (en) 2004-11-24 2006-09-14 California Institute Of Technology Biosensors based upon actuated desorption
WO2006065598A2 (en) 2004-12-13 2006-06-22 Geneohm Sciences, Inc. Fluidic cartridges for electrochemical detection of dna
RU2377571C2 (en) 2005-01-07 2009-12-27 Секисуй Кемикал Ко., Лтд. Detector device with cartridge
US7972697B2 (en) * 2005-01-26 2011-07-05 Honda Motor Co., Ltd. Electrochemical activation of capacitor material
EP1850747A2 (en) 2005-02-11 2007-11-07 The University Court Of The University Of Glasgow Sensing device, apparatus and system, and method for operating the same
KR101637140B1 (en) 2005-05-09 2016-07-06 테라노스, 인코포레이티드 Point-of-care fluidic systems and uses thereof
US20060275852A1 (en) 2005-06-06 2006-12-07 Montagu Jean I Assays based on liquid flow over arrays
US7938573B2 (en) 2005-09-02 2011-05-10 Genefluidics, Inc. Cartridge having variable volume reservoirs
JP4907983B2 (en) * 2005-12-26 2012-04-04 株式会社Ｋｒｉ Bio-related substance detection device
US7566410B2 (en) 2006-01-11 2009-07-28 Nanotek Instruments, Inc. Highly conductive nano-scaled graphene plate nanocomposites
US7887682B2 (en) * 2006-03-29 2011-02-15 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7598091B2 (en) 2006-04-04 2009-10-06 Micropoint Bioscience, Inc. Micromachined diagnostic device with controlled flow of fluid and reaction
US7449133B2 (en) 2006-06-13 2008-11-11 Unidym, Inc. Graphene film as transparent and electrically conducting material
AU2007265628B2 (en) 2006-06-23 2012-12-06 Revvity Health Sciences, Inc. Methods and devices for microfluidic point-of-care immunoassays
GB0618966D0 (en) 2006-09-26 2006-11-08 Iti Scotland Ltd Cartridge system
WO2008049075A2 (en) 2006-10-18 2008-04-24 Agamatrix, Inc. Electrochemical determination of analytes
EP2097750A2 (en) 2006-10-26 2009-09-09 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US8691592B2 (en) 2006-12-14 2014-04-08 The Trustees Of The University Of Pennsylvania Mechanically actuated diagnostic device
US8506908B2 (en) 2007-03-09 2013-08-13 Vantix Holdings Limited Electrochemical detection system
CA2699386C (en) 2007-09-13 2016-08-09 Abbott Point Of Care Inc. Improved quality assurance system and method for point-of-care testing
JP2011501161A (en) * 2007-10-17 2011-01-06 オームクス コーポレーション New chemistry for biosensors
JP2011504591A (en) 2007-11-26 2011-02-10 アトノミックス アクティーゼルスカブ Integrated separation and detection cartridge with means and methods for increasing the signal to noise ratio
US8883114B2 (en) 2007-12-26 2014-11-11 Nanotek Instruments, Inc. Production of ultra-thin nano-scaled graphene platelets from meso-carbon micro-beads
US9564629B2 (en) 2008-01-02 2017-02-07 Nanotek Instruments, Inc. Hybrid nano-filament anode compositions for lithium ion batteries
US8936874B2 (en) 2008-06-04 2015-01-20 Nanotek Instruments, Inc. Conductive nanocomposite-based electrodes for lithium batteries
CN102138075B (en) 2008-10-01 2014-05-28 三星电子株式会社 Centrifugal-based microfluid apparatus, method of fabricationg the same, and method of testing samples using the microfluidic apparatus
WO2010048494A1 (en) 2008-10-24 2010-04-29 Qualigen, Inc. Improved sample injection port for laminated devices
US20100143194A1 (en) 2008-12-08 2010-06-10 Electronics And Telecommunications Research Institute Microfluidic device
WO2010080115A2 (en) 2008-12-18 2010-07-15 Claros Diagnostics, Inc. Improved reagent storage in microfluidic systems and related articles and methods
US8084272B2 (en) 2009-03-25 2011-12-27 Abbott Point Of Care Inc. Amelioration of heterophile antibody immunosensor interference
EP2270506A3 (en) 2009-07-02 2011-03-09 Amic AB Amplified labeled conjugate for use in immunoassays
GB2473425A (en) 2009-09-03 2011-03-16 Vivacta Ltd Fluid Sample Collection Device
EP2504466B1 (en) 2009-11-23 2019-11-20 Proxim Diagnostics Corporation Controlled electrochemical activation of carbon-based electrodes
EP4060325B1 (en) 2009-12-07 2024-08-21 Meso Scale Technologies, LLC. Assay cartridge reader
US20120255860A1 (en) 2009-12-24 2012-10-11 Proxim Diagnostics Carbon-based electrodes with graphene modification
BR112012018115B1 (en) 2010-01-23 2021-06-22 Genefluidics, Inc. SYSTEM CONFIGURED TO TRANSPORT A LIQUID STORED IN ONE OR MORE RESERVOIRS WITHIN ONE OR MORE FUNCTIONAL CHAMBERS, AND METHOD OF OPERATION OF THE SYSTEM
US9636053B2 (en) 2010-02-12 2017-05-02 Neustar, Inc. Method for distributing contact information between applications
CA3016967C (en) 2010-04-16 2021-08-31 Opko Diagnostics, Llc Systems and devices for analysis of samples
GB201014805D0 (en) 2010-09-07 2010-10-20 Multi Sense Technologies Ltd Microfluidics based assay device
WO2013015822A1 (en) 2011-07-25 2013-01-31 Mikhail Briman Cartridge for diagnostic testing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2011062738A1 *

Also Published As

Publication number Publication date
WO2011062738A1 (en) 2011-05-26
JP5792181B2 (en) 2015-10-07
EP2504466A4 (en) 2016-02-24
US20120242345A1 (en) 2012-09-27
US20150168331A1 (en) 2015-06-18
US10041900B2 (en) 2018-08-07
EP2504466B1 (en) 2019-11-20
US9000769B2 (en) 2015-04-07
JP2013511716A (en) 2013-04-04

Similar Documents

Publication Publication Date Title
CN101595381B (en) Electrode plate for electrochemical measurement, electrochemical measuring apparatus having the electrode plate, and method for determining target substance by using the electrode plate
US9976168B2 (en) Substance measurement method and measurement device employing electrochemical biosensor
CA2535833C (en) Method and apparatus for assay of electrochemical properties
US6740214B1 (en) Microelectrode biosensor and method therefor
JPH0815220A (en) Quantitative method for specific compound and its apparatus
US10041900B2 (en) Controlled electrochemical activation of carbon-based electrodes
KR20170002112A (en) Biosensor and biosensor array
TWI495872B (en) Electrochemical bio-affinity sensing chips integrated with fluidic stirring and operation method thereof
CN101627301A (en) Electrode plate for electrochemical measurement, electrochemical measuring instrument having the electrode plate for electrochemical measurement, and method for determining target substance using the
JPS59176662A (en) semiconductor sensor
JPH04279854A (en) Platinum coated carbon fiber electrode and enzymatic film sensor using same
CN112268938B (en) NOx gas sensor
JPH06324015A (en) Bio sensor and its manufacture
EP3454057A1 (en) Measuring method and measuring apparatus
Berney Capacitance affinity biosensors
EP3803363B1 (en) Glucose sensing device
JP3631740B6 (en) Biosensor enzyme electrode and method for producing the same
JP3631740B2 (en) Biosensor enzyme electrode and method for producing the same
KR20190056821A (en) Method for measuring the concentration of target substance in a testing sample using a electrochemical sensor for point of care self-diagnosis
JP2009276276A (en) Measuring device and measurement method using the same
WO2012084152A1 (en) Controlled slew rate transition for electrochemical analysis
AU2013204819A1 (en) Method and apparatus for assay of electrochemical properties

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120622

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PROXIM DIAGNOSTICS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: PROXIM DIAGNOSTICS

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20160127

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BRIMAN, MIKHAIL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20170324

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PROXIM DIAGNOSTICS CORPORATION

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 27/327 20060101ALI20190416BHEP

Ipc: C25C 7/00 20060101AFI20190416BHEP

Ipc: G01N 27/30 20060101ALI20190416BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20190528

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602010062073

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1204286

Country of ref document: AT

Kind code of ref document: T

Effective date: 20191215

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20191120

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200220

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200221

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200220

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200320

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200412

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1204286

Country of ref document: AT

Kind code of ref document: T

Effective date: 20191120

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602010062073

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20200821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201029

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20201031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201031

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201031

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201029

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602010062073

Country of ref document: DE

Representative=s name: SIMMONS & SIMMONS LLP, DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191120

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20250904

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20250908

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20250902

Year of fee payment: 16